| 000 | 01547 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512044733.0 | ||
| 264 | 0 | _c19870901 | |
| 008 | 198709s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/bjc.1987.107 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCuzick, J | |
| 245 | 0 | 0 |
_aA comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cMay 1987 |
||
| 300 |
_a523-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xchemically induced |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aErskine, S | |
| 700 | 1 | _aEdelman, D | |
| 700 | 1 | _aGalton, D A | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 55 _gno. 5 _gp. 523-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1987.107 _zAvailable from publisher's website |
| 999 |
_c3306516 _d3306516 |
||